| Autor: |
T E, Shmidt, T D, Zhuchenko, N N, Iakhno |
| Rok vydání: |
2003 |
| Předmět: |
|
| Zdroj: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2) |
| ISSN: |
1997-7298 |
| Popis: |
Multiple sclerosis (MS)--autoimmune disease of CNS, characterized by myelin destruction and axonal damage. The action of drugs recommended for its treatment [symbol: see text] aimy[symbol: see text] at the reduction of the autoimmune responses. These responses lead to the neurological damage. One of immunoregulators is glatiramer acetate--Copaxone. Copaxone acts at different phases of MS pathogenesis and probably has a neuroprotective action. Copaxone reduces the rate of relapses and leads to clinical stabilisation in cases of relapsing-remmiting MS. Its efficacy and safety has been confirmed in long-term clinical and MRI-trials. Copaxone has few side-effects that are non-significant. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
